Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
Clinical Study of the Utility of a Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
This observational or N/A phase trial investigates Brain Tumor and Glioma and is currently completed. H. Lee Moffitt Cancer Center and Research Institute leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
-
Jan 2022 — Jun 2022 [monthly]
Completed
-
Sep 2021 — Jan 2022 [monthly]
Completed
▶ Show 9 earlier versions
-
Mar 2021 — Sep 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jul 2020 — Dec 2020 [monthly]
Active Not Recruiting
-
Mar 2020 — Jul 2020 [monthly]
Active Not Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2019 — Feb 2020 [monthly]
Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Recruiting
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- H. Lee Moffitt Cancer Center and Research Institute
- Olympus Corporation
For direct contact, visit the study record on ClinicalTrials.gov .